Skip to content
10-K

Annual Report

Rocket Pharmaceuticals, Inc. RCKT RCKTW

0001193125-26-076551

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 108.57M sh
Shares Diluted FY 2025 · Dec 31, 2025 111.12M sh
Shares Diluted FY 2025 · Dec 31, 2024 94.81M sh
Capex FY 2025 · Dec 31, 2025 $440K
Capex FY 2025 · Dec 31, 2024 $5.86M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$190.01M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$209.72M
Short Term Investments FY 2025 · Dec 31, 2025 $111.37M
Short Term Investments FY 2025 · Dec 31, 2024 $208.7M
Cash And Equivalents FY 2025 · Dec 31, 2025 $77.56M
Cash And Equivalents FY 2025 · Dec 31, 2024 $163.64M
Stockholders Equity FY 2025 · Dec 31, 2025 $277.22M
Stockholders Equity FY 2025 · Dec 31, 2024 $463.23M
Stockholders Equity FY 2025 · Dec 31, 2023 $492.57M
Current Liabilities FY 2025 · Dec 31, 2025 $30.21M
Current Liabilities FY 2025 · Dec 31, 2024 $40.68M
Total Liabilities FY 2025 · Dec 31, 2025 $53.23M
Total Liabilities FY 2025 · Dec 31, 2024 $64.47M
Current Assets FY 2025 · Dec 31, 2025 $192.73M
Current Assets FY 2025 · Dec 31, 2024 $378.18M
Total Assets FY 2025 · Dec 31, 2025 $330.45M
Total Assets FY 2025 · Dec 31, 2024 $527.7M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.01
Eps Diluted FY 2025 · Dec 31, 2024 −$2.73
Eps Basic FY 2025 · Dec 31, 2025 −$2.01
Eps Basic FY 2025 · Dec 31, 2024 −$2.73
Sga Expense FY 2025 · Dec 31, 2025 $86.5M
Sga Expense FY 2025 · Dec 31, 2024 $101.96M
Rd Expense FY 2025 · Dec 31, 2025 $142.02M
Rd Expense FY 2025 · Dec 31, 2024 $171.24M
Net Income FY 2025 · Dec 31, 2025 −$223.12M
Net Income FY 2025 · Dec 31, 2024 −$258.75M
Operating Income FY 2025 · Dec 31, 2025 −$231.75M
Operating Income FY 2025 · Dec 31, 2024 −$273.21M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $0